JCAHPO and EyeCareCE would like to recognize the following organizations for contributing time, resources, and material to the continuing education of ophthalmic allied health personnel.
Delta Gamma Foundation
The Delta Gamma society has been involved in charitable philanthropy since its inception in 1873, and specifically adopting Sight Conservation and Aid to the Blind as a core effort in 1937, though the foundation itself was not incorporated until 1951. Delta Gamma's work for the visually impaired became unique among philanthropies as members answered the needs within their own communities as well as on the international scene.
Essilor is the leading manufacturer of optical lenses in the United States and is the market leader in progressive, high-index and anti-reflective coated lenses. A pioneer in the development and production of ophthalmic lenses, Essilor employs more than 9,000 people throughout North America. Essilor of America, Inc., (Essilor) is a subsidiary of Paris-based Essilor International, S.A.
Ophthalmic Mutual Insurance Company (OMIC)
The Ophthalmic Mutual Insurance Company (OMIC) is the largest professional liability insurer of ophthalmologists in America and is the only endorsed carrier of the American Academy of Ophthalmology. OMIC is the nation's premier source for ophthalmic-specific risk management education.
Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year.
Readers Digest Partners for Sight Foundation
Partners for Sight is dedicated to increasing the self-reliance and dignity of blind and visually impaired persons. We believe these individuals should have the tools and resources necessary to lead independent, productive lives. Through our support of non-profit organizations that share this philosophy, we’re making the world easier to navigate for thousands of people, every day.
TearLab is pioneering the future of tear film diagnostics to elevate patient care. Using its first of a kind point-of-care ophthalmic in vitro diagnostic platform, TearLab allows you to add data to your insights to guide the diagnosis and management of the ocular surface. With precise and predictive information available in a matter of seconds, you are able to evaluate tear film health, uncover abnormal osmolarity, inform your treatment plan based on severity, and manage patient progress. The TearLab osmolarity test is CLIA waived and has a specific CPT reimbursement code.